WolverHeme Happy Hour

A podcast by Bernard Marini, Anthony Perissinotti, et al.

31 Episodes

  1. Pour Decisions, or ASH-olutely Fabulous? Reviewing 2024 ASH Lymphoma Updates

    Published: 24/12/2024
  2. A Bunch of ASHholes Discuss Myeloma Abstracts

    Published: 16/11/2024
  3. Cast your vote! Nivolumab vs. Brentuximab for Classical Hodgkin Lymphoma

    Published: 08/11/2024
  4. Episode 27: Mantle Cell Masterclass with Tycel Phillips

    Published: 10/10/2024
  5. Houston, we don't have a problem... with APOLLO

    Published: 28/08/2024
  6. From Ancient Remedies to Modern Miracles: The Evolution of APL Treatment

    Published: 13/06/2024
  7. Episode 24: Myeloma Madness with the Myeloma Man

    Published: 17/04/2024
  8. Anthony and Bernie get rich on no-larabine! An ASH 2023 ALL discussion

    Published: 25/01/2024
  9. LymphOMG: Pouring Over Lymphoma Abstracts from ASH

    Published: 29/12/2023
  10. AMLchemy at ASH: Brewing Success with Menin Magic, MRD Mysteries, and Aza/Ven Alchemy

    Published: 19/12/2023
  11. ASH Pregaming - Myeloma Madness with Manni and Papa Heme

    Published: 01/12/2023
  12. AML Maintenance Part 2: a metaMORPHOsis?

    Published: 08/11/2023
  13. AML Maintenance Part 1: Set Your QUAZARs to Stun

    Published: 25/10/2023
  14. Episode 17: The Hemophilia Eras Tour

    Published: 23/08/2023
  15. Common Sense Oncology: Outcomes That Matter

    Published: 01/08/2023
  16. All too well: the reality of leukemia treatment

    Published: 08/06/2023
  17. Episode 14: A Quantum Leap in AML Treatment? Dissecting Quizartinib Data with Dr. Dale Bixby

    Published: 09/05/2023
  18. Episode 13: You get blinatumomab! You get blinatumomab!

    Published: 24/02/2023
  19. Episode 12: Tinder for T Cells - Bispecifics in DLBCL

    Published: 08/02/2023
  20. Episode 11: "Olu the Drunk Snowman" - IDH inhibitors in R/R AML with Dr. Jill Lykon

    Published: 21/01/2023

1 / 2

Welcome to WolverHeme Happy Hour! This is a podcast dedicated to all things hematology! We discuss new data, debate controversial therapies, and talk about new and exciting research. While we nerd out about data, we'll have a few drinks! Disclaimer: The views and opinions expressed on this podcast are solely those of the podcasters and guests and do not reflect the views or opinions of our employers or other affiliations.

Visit the podcast's native language site